0001179110-14-018246.txt : 20141216
0001179110-14-018246.hdr.sgml : 20141216
20141216163648
ACCESSION NUMBER: 0001179110-14-018246
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141215
FILED AS OF DATE: 20141216
DATE AS OF CHANGE: 20141216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HOSPIRA INC
CENTRAL INDEX KEY: 0001274057
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 275 FIELD DR
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
BUSINESS PHONE: 8479376472
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Werner Thomas E
CENTRAL INDEX KEY: 0001372882
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31946
FILM NUMBER: 141290045
MAIL ADDRESS:
STREET 1: C/O HOSPIRA, INC.
STREET 2: 275 NORTH FIELD DRIVE
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
4
1
edgar.xml
FORM 4 -
X0306
4
2014-12-15
0
0001274057
HOSPIRA INC
HSP
0001372882
Werner Thomas E
C/O HOSPIRA, INC.
275 NORTH FIELD DRIVE
LAKE FOREST
IL
60045
0
1
0
0
SVP, Finance & CFO
Common Stock
2014-12-15
4
M
0
10000
43.180
A
64614
D
Common Stock
2014-12-15
4
S
0
9100
60.803
D
55514
D
Common Stock
2014-12-15
4
S
0
900
61.387
D
54614
D
Stock Options (Right to Buy)
43.180
2014-12-15
4
M
0
10000
0
D
2015-03-05
Common Stock
10000
11566
D
Exercise of derivative security exempted pursuant to Rule 16b-3.
The stock options vest in three equal annual installments on March 6, 2009, 2010, and 2011. The exercise price of $43.18 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on March 5, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.31 to $61.29, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.31 to $61.48, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
Traded pursuant to a 10b5-1 plan.
Benjamin Kwakye, Attorney in Fact
2014-12-16